NKECHINYERE NWOSU: Open Payments
NPI 1245711621 · FORT THOMAS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 59 payments from 13 companies in 2025. Trend: 2023 $834 · 2024 $1,170 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $253 |
| Axsome Therapeutics, Inc. | 7 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $181 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Novo Nordisk Inc | 4 | $71 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $35 |
Products named: VRAYLAR, Auvelity, CAPLYTA, Wegovy, INGREZZA, REXULTI, TRINTELLIX, HETLIOZ.
Industry payments across KY — which companies pay providers there.
